Barclays lowered the firm’s price target on Carlyle (CG) to $43 from $55 and keeps an Overweight rating on the shares as part of a Q1 preview for the brokers, asset managers and exchanges. With volatility “in full swing,” mergers and initial public offering pipelines are likely to see further delays, the analyst tells investors in a research note. The firm says that while trading activity was generally robust despite a slowdown in crypto, brokers “now face a more intense headwind from a lower in-period Fed funds and futures curve.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Opening Day: Klarna, Chime join StubHub in postponing IPOs
- Backstone, Carlyle-backed Medline postpones IPO, FT reports
- Carlyle price target lowered to $46 from $47 at BofA
- Private Equity Stocks Crash as Tariffs Threaten Dealmaking for KKR and Apollo
- TransDigm, PE firms among bidders for Boeing navigation unit, Reuters reports